Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| 4,5,6,7-Tetrabromo-N,N-dimethyl-1H-benzimidazol-2-amine | Ki | 112.0 [1], 133.0 [2] | |
| 4,5,6,7-Tetrabromobenzimidazole | Ki | 270.0 [1], 343.0 [2] | |
| 4,5,6,7-Tetraiodo-1H-benzimidazole | Ki | 21.0 [1], 71.0 [2] | |
| [4,5,6,7-Tetrabromo-2-(Dimethylamino)-1h-Benzimidazol-1-Yl]acetic Acid | Ki | 21.0 [1], 66.0 [2] | |
| 4-[2-[(4-Methoxyphenyl)carbonylamino]-1,3-Thiazol-5-Yl]benzoic Acid | IC50 | 11.0 [1], 46.0 [2] | |
MLA | "Quest Database™ Casein kinase II alpha (prime) Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 13 Dec. 2025, https://www.aatbio.com/data-sets/casein-kinase-ii-alpha-prime-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 13). Quest Database™ Casein kinase II alpha (prime) Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/casein-kinase-ii-alpha-prime-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |